-Down to Earth Delisting fruits and vegetables from APMC Act in Congress-ruled states will not benefit farmers Congress vice-president Rahul Gandhi last December said fruits and vegetables will become affordable if states allowed farmers to directly sell their produce to consumers. He also directed the chief ministers in Congress-ruled states to delist fruits and vegetables from the Agriculture Produce Marketing Committee (APMC) Act. The Act makes it mandatory for farmers to sell...

-AgriculturesNetwork.org The United Nations Special Rapporteur on the right to food, Olivier De Schutter, today calls for radical transformation of the world's food systems. The emphasis in agricultural policy should shift from productivity to "well-being, resilience and sustainability", he says. This morning De Schutter presented his final report to the UN Human Rights Council after a six-year term as Special Rapporteur. In February, he also presented some of his findings at...

-The Business Standard The recent US-India friction over trade is being driven by Big Pharma Apart from the deterioration of the business environment generally, which impacts both domestic and foreign investors, retrospective taxation has figured most prominently in the media as the principal cause of growing scepticism among foreign investors. Entirely missing from the discourse has been an equally potent factor with wholly foreign origins: the hijacking of the economic policy...

-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...

-The Hindu Chennai: With U.S Trade Representative Michael Froman set to announce a trade enforcement action tied to India, the highly influential U.S Chamber of Commerce has lashed out at India's recent pattern of pharma patent denials, pointing out that the country's actions "are not about access to medicine." In the case of Swiss drug-maker Novartis, whose cancer drug's patent protections were dismissed by the Supreme Court, the chamber has argued that...